AI assistant
Sending…
CEL SCI CORP — Director's Dealing 2015
Jul 1, 2015
34401_dirs_2015-07-01_94688837-4702-4ae0-8320-9de04c5910b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CEL SCI CORP (CVM)
CIK: 0000725363
Period of Report: 2015-06-29
Reporting Person: KERSTEN GEERT R (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-30 | Common Stock | A | 6022 | $0.66 | Acquired | 8800680 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-29 | Convertible Note | $0.59 | J | 1871282 | Acquired | 2017-07-06 | Common Stock (1871282) | Indirect |
| 2015-06-29 | Warrants | $0.53 | J | 2844627 | Acquired | 2017-08-18 | Common Stock (2844627) | Indirect |
Footnotes
F1: A convertible note due and payable by CEL-SCI to the de Clara Trust for $1,104,057 on July 6, 2015 was extended by 2 years. The conversion price was lowered to $0.59, the closing price on June 26, 2015.
F2: The expiration date of these warrants was extended for 2 years as part of a 2 year extension of the convertible note payable to the de Clara Trust on July 6, 2015. These warrants are owned by the de Clara Trust. Mr. Kersten is the trustee and a beneficiary of the de Clara Trust.
More from CEL SCI CORP
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 1
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 17
Interim / Quarterly Report
2026
Feb 17
Director's Dealing
2026
Jan 26